Sources | Names Used |
---|---|
CTRPv2 | decitabine:navitoclax (2:1 mol/mol) |
PharmacoGx | decitabine:navitoclax (2:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | DLX4 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.0008 |
mRNA | SPSB3 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.0008 |
mRNA | ARID2 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.0008 |
mRNA | PEA15 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0008 |
mRNA | BTN1A1 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.0008 |
mRNA | C19orf52 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.0008 |
mRNA | PCMTD2 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.0008 |
mRNA | FBXL12 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.0008 |
mRNA | KIT | CTRPv2 | pan-cancer | AAC | 0.1 | 0.0008 |
mRNA | EBNA1BP2 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.0008 |